D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Alignment Healthcare
ALHC
$3.18B
| $1.4M | ﹤0.01% |
+118,699
| New | +$1.4M |
|
1852
Encompass Health
EHC
$12.7B
| $1.4M | ﹤0.01% |
+14,477
| New | +$1.4M |
|
1853
Zynex
ZYXI
$44.8M
| $1.4M | ﹤0.01% |
171,159
-85,906
| -33% | -$701K |
|
1854
NexGen Energy
NXE
$4.36B
| $1.4M | ﹤0.01% |
+213,813
| New | +$1.4M |
|
1855
GFL Environmental
GFL
$17.1B
| $1.39M | ﹤0.01% |
+34,972
| New | +$1.39M |
|
1856
Wyndham Hotels & Resorts
WH
$6.55B
| $1.39M | ﹤0.01% |
17,849
-75,321
| -81% | -$5.89M |
|
1857
Phillips Edison & Co
PECO
$4.47B
| $1.39M | ﹤0.01% |
36,948
-52,345
| -59% | -$1.97M |
|
1858
L3Harris
LHX
$52.2B
| $1.39M | ﹤0.01% |
5,841
-3,400
| -37% | -$809K |
|
1859
Interpublic Group of Companies
IPG
$9.67B
| $1.38M | ﹤0.01% |
+43,769
| New | +$1.38M |
|
1860
International Paper
IP
$24.3B
| $1.38M | ﹤0.01% |
28,309
-291,700
| -91% | -$14.2M |
|
1861
CRISPR Therapeutics
CRSP
$5.12B
| $1.38M | ﹤0.01% |
29,365
+1,191
| +4% | +$56K |
|
1862
HealthEquity
HQY
$7.97B
| $1.38M | ﹤0.01% |
16,849
-10,377
| -38% | -$849K |
|
1863
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.8B
| $1.37M | ﹤0.01% |
+26,840
| New | +$1.37M |
|
1864
JFrog
FROG
$5.83B
| $1.37M | ﹤0.01% |
47,224
+21,214
| +82% | +$616K |
|
1865
Darling Ingredients
DAR
$4.97B
| $1.37M | ﹤0.01% |
36,899
-233,939
| -86% | -$8.69M |
|
1866
Citi Trends
CTRN
$281M
| $1.37M | ﹤0.01% |
74,488
-22,862
| -23% | -$420K |
|
1867
Kforce
KFRC
$567M
| $1.37M | ﹤0.01% |
22,247
+17,060
| +329% | +$1.05M |
|
1868
Flowserve
FLS
$7.36B
| $1.36M | ﹤0.01% |
26,407
-82,077
| -76% | -$4.24M |
|
1869
Invesco S&P 500 GARP ETF
SPGP
$2.73B
| $1.36M | ﹤0.01% |
13,034
-19,046
| -59% | -$1.99M |
|
1870
Invesco S&P 500 Pure Value ETF
RPV
$1.37B
| $1.36M | ﹤0.01% |
15,309
-9,667
| -39% | -$860K |
|
1871
Delek US
DK
$1.68B
| $1.36M | ﹤0.01% |
72,308
+11,309
| +19% | +$212K |
|
1872
BBVA Argentina
BBAR
$1.84B
| $1.35M | ﹤0.01% |
130,591
-100,640
| -44% | -$1.04M |
|
1873
Tompkins Financial
TMP
$1B
| $1.35M | ﹤0.01% |
23,432
-26,762
| -53% | -$1.55M |
|
1874
Crane NXT
CXT
$3.46B
| $1.35M | ﹤0.01% |
24,114
+3,882
| +19% | +$218K |
|
1875
Premier
PINC
$2.2B
| $1.35M | ﹤0.01% |
67,618
+10,851
| +19% | +$217K |
|